<DOC>
	<DOCNO>NCT02418091</DOCNO>
	<brief_summary>This study build population management system Simultaneous risk factor control use Telehealth slOw Progression Diabetic Kidney Disease STOP-DKD Application STOP-DKD APP conduct 6-month control trial compare reduction blood pressure . In addition , study evaluate feasibility future large-scale intervention slow diabetic kidney disease ( DKD ) DKD progression . Aim 1 : Identify patient moderate DKD uncontrolled hypertension ( HTN ) use exist electronic health record data integrate data warehouse ( Southeastern Diabetes Initiative- SEDI ) screen patient within SEDI . Aim 2 : Implement intervention design slow progression DKD treat associate condition high-risk population moderate DKD uncontrolled HTN use STOP-DKD APP - Primary Outcome : Test hypothesis patient receive intervention great improvement blood pressure compare control group 6 month - Secondary Outcomes : Exploratory analysis determine whether patient receive intervention less progression ( define small decrease kidney function ) , improved behavior affect HTN control cardiovascular risk ( medication adherence , diet , physical activity , weight control ) compare control group 6 month Aim 3 : Evaluate STOP-DKD APP Study guide large-scale implementation &amp; dissemination - Impact Evaluation : Assess potential population impact intervention use Reach , Effectiveness , Adoption , Implementation , Maintenance ( RE-AIM ) framework - Economic Evaluation : Conduct economic evaluation use Archimedes Model estimate project cost quality-adjusted life-years</brief_summary>
	<brief_title>Integrated Population Program Diabetic Kidney Disease</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Diabetic Nephropathies</mesh_term>
	<criteria>Potentially eligible patient identify use exist SEDI ( Southeastern Diabetes Initiative ) data warehouse pull electronic health record data quarterly ten different source system four county . Adults ( age ≥18 75 year ) ; Diagnosis type 2 diabetes ( ICD9 cod 250.x0 , 250.x2 ) ; Have least 2 serum creatinine value available 3 prior year , separate least 3 month ; Preserved kidney function ( base upon last year 's eGFR average 4590 ml/min/1.73m2 , estimate calculate eGFR use 4variable Modification Diet Renal Disease study equation ) ; Evidence diabetic nephropathy ( Either : 1. presence macroalbuminuria ; 2. history microalbuminuria prior ACE ( angiotensinconverting enzyme ) inhibitor angiotensin receptor blocker ( ARB ) therapy ; 3. previous documentation diabetic retinopathy laser therapy ; 4. microalbuminuria # 3 , urinalysis without hematuria , renal etiology [ i.e. , glomerulonephritis , polycystic kidney disease , membranous nephropathy , renal artery stenosis ] ) Uncontrolled HTN ( 1y mean clinic SBP≥140 and/or DBP≥90 ) . Patients meet one exclusion criterion exclude : No access telephone Not proficient English Nursing home/longterm care facility resident receive home health care Impaired hearing/ speech/ vision Participating another trial ( pharmaceutical behavioral ) Planning leave area next 3 year Pancreatic insufficiency diabetes secondary pancreatitis Alcohol abuse ( &gt; 14 alcoholic beverages/ wk ) Diagnosis nondiabetic kidney disease Active malignancy ( nonmelanomatous skin cancer ) Diagnosis lifethreatening disease death probable within 4 year .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>patient moderate DKD uncontrolled HTN</keyword>
</DOC>